Drolmi - 40
- Home
- Drolmi - 40
Drolmi - 40
- Most homogeneous BP Control
- Additional CV risk benefit especially due to buffering of BP variability.
- Excellent safety Profile.
- Some Antiarthrogenic and Vasoprotective effects.
- Better than Telmisartan in treating cardiac patients with Diabetes.